BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2721666)

  • 1. Evidence that the anti-coagulant and lethal properties of a basic phospholipase A2 from snake venom are unrelated.
    Chwetzoff S; Couderc J; Frachon P; Menez A
    FEBS Lett; 1989 May; 248(1-2):1-4. PubMed ID: 2721666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
    Lane J; O'Leary MA; Isbister GK
    Toxicon; 2011 Sep; 58(3):239-46. PubMed ID: 21723878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant Activity of
    Kazandjian TD; Arrahman A; Still KBM; Somsen GW; Vonk FJ; Casewell NR; Wilkinson MC; Kool J
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33922825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mode of action of basic phospholipase A2 from Naja nigricollis venom.
    Chwetzoff S
    Biochim Biophys Acta; 1990 Aug; 1045(3):285-90. PubMed ID: 2386800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical cross-reactivity of neurotoxic phospholipase A2 enzymes from Indian cobra (Naja naja naja) venom using polyclonal antibodies.
    Basavarajappa BS; Guru SC; Gowda TV
    Toxicon; 1993 Sep; 31(9):1167-77. PubMed ID: 7505490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between high-affinity noncatalytic binding of snake venom phospholipases A2 to brain synaptic plasma membranes and their central lethal potencies.
    Rapuano BE; Yang CC; Rosenberg P
    Biochim Biophys Acta; 1986 Apr; 856(3):457-70. PubMed ID: 3964691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the hemolysis of human erythrocytes by cardiotoxins from Naja naja kaouthia and Naja naja atra venoms and a phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom.
    Jiang MS; Fletcher JE; Smith LA
    Toxicon; 1989; 27(2):247-57. PubMed ID: 2718193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of enzymatic and pharmacological activities of lysine-49 and aspartate-49 phospholipases A2 from Agkistrodon piscivorus piscivorus snake venom.
    Dhillon DS; Condrea E; Maraganore JM; Heinrikson RL; Benjamin S; Rosenberg P
    Biochem Pharmacol; 1987 May; 36(10):1723-30. PubMed ID: 3109429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationships among neurotoxic phospholipases: NN-XIII-PLA2 from Indian cobra (Naja naja naja) and VRV PL-V from Russell's viper (Vipera russelli) venoms.
    Bhat MK; Kasturi S; Gowda TV
    Toxicon; 1991; 29(1):97-105. PubMed ID: 2028476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical properties of Naja naja atra (Taiwan cobra) phospholipase A2 using polyclonal and monoclonal antibodies.
    Yang CC; Chang LS; Ong PL; Tung TH
    Toxicon; 1992 Feb; 30(2):151-9. PubMed ID: 1373010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lethal in vivo and cytotoxic in vitro properties of a basic phospholipase A2 modified with para-bromophenacyl bromide].
    Chwetzoff S; Ménez A
    C R Acad Sci III; 1988; 307(2):29-32. PubMed ID: 3138001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic relatedness between phospholipases A2 from Naja naja venom and from mammalian cells.
    Masliah J; Kadiri C; Pepin D; Rybkine T; Etienne J; Chambaz J; Bereziat G
    FEBS Lett; 1987 Sep; 222(1):11-6. PubMed ID: 2443388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a myotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Bhat MK; Gowda TV
    Toxicon; 1989; 27(8):861-73. PubMed ID: 2781585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody recognizing a conserved epitope in a group of phospholipases A2.
    Mollier P; Chwetzoff S; Ménez A
    Mol Immunol; 1990 Jan; 27(1):7-15. PubMed ID: 1690350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom--II. Pharmacological properties in relationship to enzymatic activity.
    Fletcher JE; Rapuano BE; Condrea E; Yang CC; Ryan M; Rosenberg P
    Biochem Pharmacol; 1980 Jun; 29(11):1565-74. PubMed ID: 7396987
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of arginine modification of Naja nigricollis and Naja naja atra snake venom phospholipases A2 on enzymatic activity, lethality and anticoagulant action.
    Condrea E; Rapuano BE; Fletcher JE; Yang CC; Rosenberg P
    Toxicon; 1981; 19(5):721-5. PubMed ID: 7302958
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and pharmacological screening of snake (Bothrops) venoms: characterization of components acting on blood coagulation and platelet aggregation.
    Zingali RB; Francischetti IM; Carlini CR; Guimarães JA
    Braz J Med Biol Res; 1988; 21(4):763-5. PubMed ID: 3240377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of clotting complexes of the extrinsic coagulation cascade by the phospholipase A2 isoenzymes from Naja nigricollis venom.
    Stefansson S; Kini RM; Evans HJ
    Thromb Res; 1989 Aug; 55(4):481-91. PubMed ID: 2814939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of two acidic phospholipase A2 enzymes from king cobra (Ophiophagus hannah) snake venom.
    Tan NH; Saifuddin MN
    Int J Biochem; 1990; 22(5):481-7. PubMed ID: 2347427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of the histidine residue in basic phospholipase A2 from the venom of Naja nigricollis.
    Yang CC; King K
    Biochim Biophys Acta; 1980 Aug; 614(2):373-88. PubMed ID: 7407195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.